Congenital Lung Lesions (CPAM)
Favorable histology Wilms tumor comprises three histologic components: blastemal, stromal, and epithelial; tumors containing only two of these components retain favorable classification. Wilms tumors characteristically displace adjacent structures outward rather than infiltrating around them, a growth pattern that distinguishes them from neuroblastoma.
Wilms tumor treatment involves surgery and chemotherapy, with the specific approach depending on tumor extent. For unilateral tumors, the strategy is nephrectomy (removal of the whole kidney). For bilateral Wilms tumors—which occur in 8 to 10% of children—the approach differs to avoid forcing dialysis; the strategy avoids removing both kidneys. Patients with lung lesions (metastatic disease) receive 3-drug chemotherapy. Treatment protocols vary between COG (North American) and SIOP (Western European) approaches, which have taken different directions in their management strategies.
Management of Wilms tumor depends on laterality. For unilateral tumors, the strategy is complete nephrectomy. For bilateral Wilms tumors (8–10% of cases), the approach differs: rather than removing both kidneys and forcing dialysis, treatment involves chemotherapy and nephron-sparing strategies. Bilateral tumors require careful attention because discordant pathology occurs in up to 20% of cases between kidneys. Favorable histology tumors contain blastemal, stromal, and epithelial components; tumors with only two components remain favorable. Treatment protocols have evolved from varied historical approaches to more standardized regimens.
Favorable histology Wilms tumor comprises three components: blastemal, stromal, and epithelial. Tumors containing all three components are classic triphasic tumors; however, tumors with only two of these components are still classified as favorable histology. The stromal and epithelial elements, including glomerular structures and the amount of stroma, characterize the favorable histology pattern.
- CVR >1.6 predicts hydrops; prophylactic steroids achieve ~100% survival vs. 49% once hydrops is established. Open fetal surgery is now rare (<1/5 years).
- Surgery at 8–10 weeks is optimal: vessels smaller, anatomy fresh, minimal inflammation. Waiting beyond 3–4 months produces fissural inflammation complicating dissection.
- Vascular control: two seals 4–5 mm apart, cut partway to verify. Never take pulmonary vein trunk near pericardium—device failure causes fatal retraction.
- PPB is radiologically indistinguishable from CPAM; ~4% of cystic lesions are PPB. Prenatally diagnosed lesions carry near-zero PPB risk; postnatal diagnosis ~10% malignancy.
- Extralobar sequestrations without airway communication have minimal infection/malignancy risk; observation is reasonable. Intralobar lesions carry 20–40% infection risk.
Congenital lung lesions, including CPAM (congenital pulmonary airway malformation), are abnormal areas of lung tissue that develop before birth [e4463-c1, e4463-c2]. Most babies with these lesions are born healthy and have no breathing problems [e5319-c1, e5319-c5]. The lesions typically grow during the first half of pregnancy and then stop growing around week 28 . Doctors can see them on prenatal ultrasounds, and most do not require any treatment before birth [e1027-c3, e1088-c18]. A small number of babies with very large lesions may develop fluid buildup (hydrops), which is serious, but this can sometimes be treated with steroids given to the mother [e1027-c5, e1027-c7, e4463-c9]. After birth, doctors usually recommend surgery to remove the affected part of the lung, typically around 2–3 months of age, because waiting longer can lead to infections that make surgery harder [e419-c15, e420-c14, e4911-c10]. The surgery is often done with small incisions (thoracoscopy), and most babies go home within a few days [e1006-c20, e2227-c27]. Doctors recommend surgery partly because untreated lesions can become infected and, very rarely, may be associated with unusual tumors, though the overall risk is low [e307-c6, e307-c7, e883-c17, e5319-c10].